Cause IQ organization profile

Dana-Farber Cancer Institute

Program areas | Form 990s | Financials | Vendors | Personnel | Peers

Dana-Farber Cancer Institute is a cancer organization based in Boston, MA that was founded in 1951. As of 2018 they had $1.7 billion in revenue and $2.8 billion in assets.

Dana-Farber Cancer Institute is committed to providing expert, compassionate care to children and adults with cancer, while advancing the understanding, treatment, cure, and prevention of cancer and related diseases.

Previous legal names or variations of their name include: Steven Connolly.

Fiscal year end:
Revenue trends:
Asset trends:

Program areas at Dana-Farber Cancer Institute

Clinical Care As one of the leading cancer centers in the world, Dana-Farber provides compassionate, comprehensive and personalized care to adults and children with cancer, blood disorders and related diseases. In 2018, our expert clinicians and caregivers at our specialized treatment centers worked together to deliver the latest therapies to our patients through 1,304 inpatient admissions, 346,805 outpatient MD visits and 176,630 infusion treatments. SINCE ITS FOUNDING IN 1947 BY SIDNEY FARBER, MD, DANA-FARBER HAS FOLLOWED HIS VISION FOR A CANCER CENTER THAT IS JUST AS DEDICATED TO DISCOVERIES IN CANCER RESEARACH AS IT IS TO DELIVERING EXPERT COMPASSIONATE CARE. DANA-FARBER IS A FOUNDING MEMBER OF DANA-FARBER/HARVARD CANCER CENTER AND ONE OF 49 NCI-DESIGNATED COMPREHENSIVE CANCER CENTERS IN THE U.S. DANA-FARBER IS THE ONLY HOSPITAL RANKED IN THE TOP FOUR NATIONALLY BY U.S. NEWS AND WORLD REPORT IN BOTH ADULT AND PEDIATRIC CANCER CARE. IN 2018, WE OFFERED MORE THAN ...

COMMUNITY BENEFITS The role of Dana-Farber's Community Benefits office is to support the Institute's goal to reduce cancer risk among medically underserved populations. To that end, we work with city and state health departments, community partners, and Boston-based coalitions to assess and monitor the needs of local residents with respect to cancer control. We are on the front lines of supporting and collaborating on programs designed to eliminate disparities in breast, colon, skin, and prostate cancer; educate diverse populations about tobacco cessation, human papillomavirus (HPV) prevention and screening, and clinical trials; and strengthen the support system for medically underserved populations. In short, we are committed to making Dana-Farber's care and research findings are more accessible to everyone within and outside its walls. In FY 2018: Dana-Farbers Mammography Services provided close to 2,300 mammograms on the van and at the mammography suite in Roxbury. 1,066 individuals received breast health education on ...

Research Scientific work at Dana-Farber is based on the premise that basic and clinical investigation are complementary and reinforcing activities. To encourage this cross-pollination of ideas, the Institute has developed an organizational framework that fosters collaborations among investigators from different disciplines. The result is an intense scientific impact on a group of diseases that continue to represent one of humanitys greatest health challenges. SOME RECENT ADVANCES INCLUDE: Sensitizing cancer cells to chemotherapy: Dana-Farber scientists showed that experimental diabetes drugs can make certain types of cancer cells more vulnerable to traditional chemotherapy agents. Survey of cancer metabolites: With researchers at other institutions, DFCI scientists compiled the first systematic survey of the products of biochemical reactions within cancer cells and their relation to the advance of the disease. The results provided scientists around the world with a curated dataset with which to track changes in these protein products, called metabolites, in cancer ...

Form 990s for Dana-Farber Cancer Institute

Fiscal year endingDate received by IRSFormPDF link
2018-09Oct 3, 2019990View PDF
2017-09Oct 16, 2018990View PDF
2016-09Oct 26, 2017990View PDF
2015-09Dec 15, 2016990View PDF
2014-09Aug 5, 2015990View PDF
...and five more Form 990 PDFs

Financials for Dana-Farber Cancer Institute

Total grants, contributions, etc.$561,378,936
Program services$1,151,473,141
Investment income and dividends$2,105,559
Tax-exempt bond proceeds$0
Royalty revenue$5,203,697
Net rental income$2,320,722
Net gain from sale of non-inventory assets$23,801,776
Net income from fundraising events$-3,531,463
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$12,385,748
Total revenues$1,755,138,116

Vendors for Dana-Farber Cancer Institute

VendorServicesAmount paidDate
BlackbaudFundraising software; CRM software; Marketing software2020-03-03
██████Fundraising software2020-03-03
███████ ███ ████Fundraising software; Payment processing2020-03-03
█████████Content management system software2020-03-03
█████ ███ █████ ██ ███Tax accounting2019-07-23
████ ███Audit accounting2019-04-19
███████ ███ ███████ ████████Medical Services$66,969,8452018-09-01
███████ ███ ███████ ██████████ ███Medical Services$16,567,0262018-09-01
...and 34 more vendors

Personnel at Dana-Farber Cancer Institute

NameTitleCompensationMost recent data
Laurie H. GlimcherPresident and Chief Executive Officer-May 20, 2020
James TerwilligerExecutive Vice President and Chief Operating Officer-May 20, 2020
████ ███████Chief Operating Officer and Executive Vice President$924,842Sept. 30, 2018
███████ ██ █████Senior Vice President for Finance and Chief Financial Officer-May 20, 2020
██████ ███████Senior Vice President and Chief Innovation Officer-May 20, 2020
███████ █████Director of Dana - Farber's Adult Acute Leukemia Program / Chief of Staff-May 20, 2020
███████ ██ ██████Chief of Staff and Chairman-May 20, 2020
██████ █████Senior Vice President , Chief Philanthropy Officer-May 20, 2020
███████ █████Senior Vice President, Chief People and Culture Officer-July 17, 2019
████ ████████Senior Vice President and Chief People Officer-May 20, 2020
...and 36 more key personnel

Peer cancer nonprofits

1Memorial Sloan Kettering Cancer Center (MSKCC)501(c)(3)$4.4 billionNew York, NY
2City of Hope National Medical Center501(c)(3)$1.2 billionDuarte, CA
3Seattle Cancer Care Alliance (SCCA)501(c)(3)$653 millionSeattle, WA
4St Jude Children's Research Hospital501(c)(3)$980 millionMemphis, TN
5American Cancer Society (ACS)501(c)(3)$769 millionAtlanta, GA
6Moffitt Cancer Center501(c)(3)$1.0 billionTampa, FL
7Hartford Hospital501(c)(3)$1.6 billionHartford, CT
8Memorial Sloan-Kettering Cancer Center (MSKCC)501(c)(3)$823 millionNew York, NY
9Tufts Medical Center Group Return501(c)(3)$943 millionBoston, MA
10Boston Medical Center (BMC)501(c)(3)$1.3 billionBoston, MA
11Reliant Medical Group501(c)(3)$657 millionWorcester, MA
12Berkshire Medical Center (BMC)501(c)(3)$539 millionPittsfield, MA
13Lahey Hospital and Medical Center501(c)(3)$1.0 billionBurlington, MA
14UMass Memorial Health Care Inc & Affiliates501(c)(3)$2.4 billionWorcester, MA
15Boston Children's Hospital / Children's Hospital Corporation501(c)(3)$2.0 billionBoston, MA
16Baystate Medical Center501(c)(3)$1.3 billionSpringfield, MA
17Lowell General Hospital501(c)(3)$496 millionLowell, MA
18Southcoast Health501(c)(3)$851 millionNew Bedford, MA
19Beth Israel Deaconess Medical Center (BIDMC)501(c)(3)$1.9 billionBoston, MA
20Partners HealthCare System501(c)(3)$1.3 billionSomerville, MA
21Cape Cod Healthcare and Affiliates (CCHC)501(c)(3)$915 millionHyannis, MA
22Sanford Tax Group501(c)(3)$2.0 billionSioux Falls, SD
23Hospital for Special Surgery (HSS)501(c)(3)$1.2 billionNew York, NY
24Texas Children's Hospital (TCS)501(c)(3)$2.4 billionHouston, TX
25Biomedical Research Foundation of Northwest Louisiana (BRF)501(c)(3)$659 millionShreveport, LA